QUANTUM X LABS INC. quarterly report, Q3 FY2025

Business Context and Reporting Period

Company: Viewbix Inc. (Note: Request metadata listed "Quantum X Labs Inc.", but the filing text identifies the registrant as Viewbix Inc.)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2025
Business Overview: Viewbix operates in digital advertising through two primary segments: the Search Segment (Gix Media) and the Digital Content Segment (Cortex). In March 2025, the company acquired Metagramm Software Ltd., an AI writing tool developer. The company listed on the Nasdaq Capital Market in June 2025.

Key Financial Metrics (Nine Months Ended Sept 30, 2025)

Metric 2025 (9 Months) 2024 (9 Months)
Revenue $7,731,000 $23,616,000
Operating Loss $(9,523,000) $(7,396,000)
Net Loss $(20,215,000) $(10,069,000)
Net Loss Attributable to Shareholders $(18,719,000) $(8,766,000)
Cash and Cash Equivalents (Sept 30, 2025) $2,165,000 $624,000 (Dec 31, 2024)
Total Debt (Short-term + Long-term) $2,885,000 $6,649,000 (Dec 31, 2024)
Operating Cash Flow $(2,551,000) $1,990,000

Material Changes vs. Prior Period

  • Revenue Decline: Revenue decreased by approximately 67% year-over-year, driven primarily by a significant drop in the Digital Content Segment (Cortex) due to the "Cortex Adverse Effect" (major advertisers ceasing ads on "Made for Advertising" sites) and a decline in the Search Segment due to browser technology changes.
  • Impairment Charges: The company recorded a $5,525,000 impairment loss on intangible assets and goodwill related to the Digital Content Segment, compared to $4,739,000 in the prior year period.
  • Financial Expenses: Net financial expenses surged to $11,193,000 from $2,755,000, largely due to changes in the fair value of financial instruments (embedded derivatives) associated with facility agreements entered in 2024.
  • Debt Restructuring: The company repaid significant portions of its bank loans in July 2025, reducing total debt obligations, while simultaneously raising capital through private placements and warrant exercises.

Guidance, Outlook, Risks, and Unusual Items

  • Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern for the next 12 months due to recurring losses, negative operating cash flows, and revenue declines. Financial statements do not include adjustments that might be necessary if the company cannot continue.
  • Subsequent Events (Post-Sept 30, 2025):
    • Sale of Cortex: On November 9, 2025, the company sold its 80% stake in Cortex for $800,000 ($200k cash, $600k in preferred shares of the buyer).
    • Quantum X Labs Acquisition: Entered into a non-binding term sheet to acquire 100% of Quantum X Labs Ltd. (a quantum computing/AI company) in exchange for 40% of Viewbix's post-closing capital stock.
    • Private Placement: Agreed to a private placement expected to raise approximately $3.0 million, contingent on the Quantum acquisition and shareholder approval.
  • Legal Proceedings: An insolvency petition filed against subsidiary Gix Media in March 2025 was dismissed in July 2025 following a settlement and full payment of debts to service providers.
  • Geopolitical Risk: Operations are based in Israel. While a ceasefire was reached in October 2025, the company notes ongoing volatility and risks related to regional conflict, including potential employee conscription and infrastructure damage.

Investor Verification Checklist

  • Going Concern Status: Verify the company's ability to secure the anticipated $3.0 million private placement and the closing of the Quantum X Labs acquisition, which are critical to resolving liquidity concerns.
  • Revenue Sustainability: Assess the impact of the Cortex sale on future revenue streams, as the Digital Content Segment was the primary revenue driver prior to the "Cortex Adverse Effect."
  • Dilution Impact: Review the terms of the Quantum X Labs acquisition and the November 2025 private placement, which involve significant issuance of new shares and pre-funded warrants, potentially diluting existing shareholders.
  • Debt Covenants: Confirm compliance with financial covenants (specifically positive EBITDA) required by the bank financing agreements with Leumi.
  • Impairment Validity: Evaluate the assumptions used for the $5.5 million impairment charge and the fair value of the remaining goodwill.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.